MIA researchers awarded $7.2m in NHMRC grants for health research
15 September 2021
We are pleased and proud to announce that Melanoma Institute Australia's world leading researchers at University of Sydney - Prof Georgina Long AO, Assoc Prof Alex Menzies and Professor Anne Cust - received National Health and Medical Research Council (NHMRC) grants today to further their melanoma research, taking us closer to achieving our mission of zero deaths from melanoma this decade.
Prof Georgina Long AO was awarded $3.9 million for 'Towards Zero Deaths from Melanoma: Innovative Clinical Trials with Multi-omics Analyses'. The project will develop new drug therapies using innovative clinical trial designs, collecting unique samples to understand the causes, and conquer drug resistance.
Assoc Prof Alex Menzies was awarded $1.3 million for 'Predictive biomarkers of response, resistance and toxicity with immunotherapy in melanoma'.
Prof Anne Cust was awarded $2 million for 'Tailored approaches to improve prevention and early detection of melanoma and other skin cancers'.
These successful grants demonstrate the outstanding work of our researchers and the potential impact of their projects.
Melanoma Institute Australia is affiliated with The University of Sydney.
Sydney Health Partners' goal is to ensure world class research is successfully implemented & scaled-up to benefit patients & wider society.
Promising young MIA researcher conferred with University of Sydney PhD.
Jana Pittman and Melinda Gainsford-Taylor urge Australians to be sun-safe and check their skin as they join the Game On Mole campaign in support of their much-loved coach
Cited an incredible 427 times around the world, showing its vital role in improving outcomes for people with advanced melanoma.
Honouring the exceptional impact of his work on communities around the world.
MIA's Co-Medical Directors receive University of Sydney's Vice-Chancellor's Award for Outstanding Research
Awarded for their life-saving discoveries transforming melanoma patient care.
National day of action called amidst fears COVID lockdowns have deterred patients from seeking potentially life-saving medical treatment
Recognising her pioneering work in immunotherapy in melanoma, transforming the care of patients worldwide.
Clinicians and researchers from across Australia and beyond united online, bringing the AMC2021 conference theme of Promising Futures to life.
Melanoma Institute Australia is proud to announce that the Nine Network’s Peter Overton AM has joined us as a National Ambassador.
MIA is proud to announce that five of our researchers have been named on the Clarivate Annual Highly Cited Researchers™ 2021 list.
New research shows routine skin checks by a health professional, coupled with checking your own skin, are vital in saving lives from melanoma.
With new patient figures indicating people may have deferred skin checks during the pandemic our Game On Mole campaign is more important than ever.
We are excited to announce a return to our much-loved physical Melanoma March events in March 2022!
Read more about the wonderful MIA community fundraising initiatives held recently.
Drug therapy set to become standard treatment in high-risk early stage patients to stop disease spread
Over two fun, yet challenging, days in September an intrepid group of riders and crew successfully completed the annual Melanoma Bike Bash in WA!
Prof Long AO has been recognised by Australian Academy of Health and Medical Sciences for her transformative work advancing melanoma treatments.
Three MIA researchers at University of Sydney received grants to further their important melanoma research.
COVID restrictions continue to impact fundraising for melanoma services in Riverina.